Literature DB >> 33727644

Single-copy detection of somatic variants from solid and liquid biopsy.

Ana-Luisa Silva1, Paulina Klaudyna Powalowska1, Magdalena Stolarek1, Eleanor Ruth Gray1, Rebecca Natalie Palmer1, Bram Herman2, Cameron Alexander Frayling1, Barnaby William Balmforth3.   

Abstract

Accurate detection of somatic variants, against a background of wild-type molecules, is essential for clinical decision making in oncology. Existing approaches, such as allele-specific real-time PCR, are typically limited to a single target gene and lack sensitivity. Alternatively, next-generation sequencing methods suffer from slow turnaround time, high costs, and are complex to implement, typically limiting them to single-site use. Here, we report a method, which we term Allele-Specific PYrophosphorolysis Reaction (ASPYRE), for high sensitivity detection of panels of somatic variants. ASPYRE has a simple workflow and is compatible with standard molecular biology reagents and real-time PCR instruments. We show that ASPYRE has single molecule sensitivity and is tolerant of DNA extracted from plasma and formalin fixed paraffin embedded (FFPE) samples. We also demonstrate two multiplex panels, including one for detection of 47 EGFR variants. ASPYRE presents an effective and accessible method that simplifies highly sensitive and multiplexed detection of somatic variants.

Entities:  

Year:  2021        PMID: 33727644      PMCID: PMC7966381          DOI: 10.1038/s41598-021-85545-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  26 in total

1.  Real-time monitoring of rolling-circle amplification using a modified molecular beacon design.

Authors:  Mats Nilsson; Mats Gullberg; Fredrik Dahl; Karoly Szuhai; Anton K Raap
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

2.  Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update.

Authors:  Gregory P Kalemkerian; Navneet Narula; Erin B Kennedy; William A Biermann; Jessica Donington; Natasha B Leighl; Madelyn Lew; James Pantelas; Suresh S Ramalingam; Martin Reck; Anjali Saqi; Michael Simoff; Navneet Singh; Baskaran Sundaram
Journal:  J Clin Oncol       Date:  2018-02-05       Impact factor: 44.544

Review 3.  Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.

Authors:  Christian Rolfo; Philip C Mack; Giorgio V Scagliotti; Paul Baas; Fabrice Barlesi; Trever G Bivona; Roy S Herbst; Tony S Mok; Nir Peled; Robert Pirker; Luis E Raez; Martin Reck; Jonathan W Riess; Lecia V Sequist; Frances A Shepherd; Lynette M Sholl; Daniel S W Tan; Heather A Wakelee; Ignacio I Wistuba; Murry W Wynes; David P Carbone; Fred R Hirsch; David R Gandara
Journal:  J Thorac Oncol       Date:  2018-06-06       Impact factor: 15.609

4.  Comparison of methods in the recovery of nucleic acids from archival formalin-fixed paraffin-embedded autopsy tissues.

Authors:  John B A Okello; Jaymi Zurek; Alison M Devault; Melanie Kuch; Andrew L Okwi; Nelson K Sewankambo; Gabriel S Bimenya; Debi Poinar; Hendrik N Poinar
Journal:  Anal Biochem       Date:  2010-01-15       Impact factor: 3.365

Review 5.  Reference standards for next-generation sequencing.

Authors:  Simon A Hardwick; Ira W Deveson; Tim R Mercer
Journal:  Nat Rev Genet       Date:  2017-06-19       Impact factor: 53.242

Review 6.  Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice.

Authors:  Charu Aggarwal; Christian D Rolfo; Geoffrey R Oxnard; Jhanelle E Gray; Lynette M Sholl; David R Gandara
Journal:  Nat Rev Clin Oncol       Date:  2020-09-11       Impact factor: 66.675

7.  Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma.

Authors:  Yang Yang; Yi Meng; Hang Zhang; Xiaoyan Shen; Rutian Li; Lixia Yu; Baorui Liu; Lifeng Wang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

8.  Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

Authors:  L De Mattos-Arruda; B Weigelt; J Cortes; H H Won; C K Y Ng; P Nuciforo; F-C Bidard; C Aura; C Saura; V Peg; S Piscuoglio; M Oliveira; Y Smolders; P Patel; L Norton; J Tabernero; M F Berger; J Seoane; J S Reis-Filho
Journal:  Ann Oncol       Date:  2014-07-09       Impact factor: 32.976

9.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Authors:  Aaron M Newman; Scott V Bratman; Jacqueline To; Jacob F Wynne; Neville C W Eclov; Leslie A Modlin; Chih Long Liu; Joel W Neal; Heather A Wakelee; Robert E Merritt; Joseph B Shrager; Billy W Loo; Ash A Alizadeh; Maximilian Diehn
Journal:  Nat Med       Date:  2014-04-06       Impact factor: 53.440

10.  Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group.

Authors:  James H Godsey; Angela Silvestro; J Carl Barrett; Kelli Bramlett; Darya Chudova; Ina Deras; Jennifer Dickey; James Hicks; Donald J Johann; Rebecca Leary; Jerry S H Lee; Joe McMullen; Lisa McShane; Katherine Nakamura; Aaron O Richardson; Matthew Ryder; John Simmons; Kelli Tanzella; Laura Yee; Lauren C Leiman
Journal:  Clin Chem       Date:  2020-09-01       Impact factor: 8.327

View more
  1 in total

1.  Ultra-sensitive molecular detection of gene fusions from RNA using ASPYRE.

Authors:  Eleanor R Gray; Justyna M Mordaka; Efthimia R Christoforou; Kristine von Bargen; Nicola D Potts; Christina Xyrafaki; Ana-Luisa Silva; Magdalena Stolarek-Januszkiewicz; Katarzyna Anton; Paulina K Powalowska; Simonetta Andreazza; Alessandro Tomassini; Rebecca N Palmer; Aishling Cooke; Robert J Osborne; Barnaby W Balmforth
Journal:  BMC Med Genomics       Date:  2022-10-12       Impact factor: 3.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.